We are the leading international tobacco company with products sold in over 180 countries. More about our business and performance.
How We Operate
We apply the same basic set of principles wherever we operate to ensure we manage our business in a responsible manner.
We work with non-profit organizations to address critical societal issues and improve living conditions in communities around the world.
2015 Annual Report
Find more information on latest financial information regarding PMI.
Access the slides and remarks of our presentations to the investment community.
Sign up for investor related email alerts and RSS feeds.
Three main types of tobacco are used to make the majority of cigarette blends. Learn more about tobacco types, blends, and grades.
We have the industry’s strongest and most diverse brand portfolio, led by Marlboro, the world’s best selling cigarette.
Take an interactive tour through the three stages of the fast-paced and highly automated process of cigarette production.
Health Effects of Smoking
Smoking is addictive and causes many serious diseases including cardio-vascular disease, lung cancer, and emphysema.
Tobacco Harm Reduction
Understand why we are developing products with the potential to be less harmful.
The illicit trade in cigarettes is a serious issue that harms governments, consumers, retailers, and manufacturers.
Tobacco Harm Reduction
Reduced-Risk Product Development
Learn about the types of potentially reduced-risk products that PMI is developing.
Assessing Risk Reduction
PMI's step-by-step approach to the scientific substantiation of risk reduction.
We manage our business in strict compliance with laws and regulations wherever we operate and have global programs to reduce our impact, covering water use, waste and recycling.
We have set measurable and challenging targets to reduce our carbon footprint. It is our long term goal to reduce our carbon footprint across our value chain by 30% by 2020.
Good Agricultural Practices
Through our Good Agricultural Practices program we support the communities and help protect the environment where our tobacco is grown.
Media office contacts and information
The latest news and announcements
Sign up to receive press releases
French court rejects lawsuit against tobacco companies
September 29, 2003
The Civil Court of Saint-Nazaire announced today that it had rejected a claim by the Caisse Primaire d'Assurance Maladie (CPAM) of Saint-Nazaire seeking to recover health care costs for the treatment of smoking-related diseases from certain affiliates of Philip Morris International and other tobacco companies. The CPAM is a local branch of the French social security system.
This is the first time a French court has addressed the ability of a health care provider to bring a direct action against tobacco manufacturers for the cost of treating beneficiaries who were smokers. Similar claims have been rejected in the United States and elsewhere. French courts generally have not accepted liability claims from individual smokers.
"This is an important decision since it is the first of its kind in France," Mark Friedman, Vice President and Associate General Counsel of Philip Morris International said. "These cases simply do not belong in court, and litigation is not the best way to address the matters raised. We will continue to work with the appropriate authorities to seek regulatory solutions to issues relating to smoking and health," Friedman said.
Note to the editor
The other defendants in the case are SEITA, affiliates of British American Tobacco and affiliates of Japan Tobacco International. The case was brought by the Caisse Primaire d'Assurance Maladie (CPAM) of Saint-Nazaire, which is a local branch of the French social security system.
More Press Releases
Set cookie preferences